06:34 EST Dynavax (DVAX) jumps 37% to $15.31 after buyout offer from Sanofi (SNY)
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DVAX:
- Sanofi to acquire Dynavax for $15.50 per share in cash, or $2.2B
- Sanofi (SNY) Acquires Dynavax in $2.2 Billion Deal after FDA Rebuff
- Dynavax Technologies Reports Strong Q3 Earnings and Strategic Growth
- Dynavax’s Promising Growth and Strategic Initiatives Justify Buy Rating with $25 Target
- Dynavax reports Q3 EPS 21c vs. 12c last year